MDM2
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
October, 2024
October 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Sep
MDM2
Jun 2, 2024, 12:11 |
Blog
New clinical data being presented at the ASCO from our ongoing KT-253 Phase 1 oncology trial - Kymera Therapeutics
Pearl Freier, Founder of Cambridge BioPartners, shared a post by Kymera Therapeutics on X/Twitter: "…
May 17, 2024, 04:29 |
Insight
Rasoul Pourebrahim: New potential targets for preventing AML with p53 mutations
Rasoul Pourebrahim, Assistant Professor at MD Anderson Cancer Centre, shared on LinkedIn: "Our paper was…
May 12, 2024, 06:02 |
Insight
Rasoul Pourebrahim: Our latest publication on studying mutant p53-driven Acute Myeloid Leukemia
Rasoul Pourebrahim, Assistant Professor at MD Anderson, made the following post on LinkedIn: "Our paper…
Mar 26, 2024, 00:22 |
Opinion
Wafik S. El-Deiry: WIN Consortium in cancer personalized medicine MTB had well over 30 participants
Wafik S. El-Deiry shared on LinkedIn: "Today’s WIN Consortium in cancer personalized medicine MTB had well…
All:
4
Posts:
1 - 100
Jane Fonda Breast Cancer and Non-Hodgkin Lymphoma: How She Went Against, How She Survived, and More
Inside OncoDaily Party Barcelona
Zainab Shinkafi-Bagudu has been elected as UICC President-Elect 2024-2026
Agenus CEO Dr. Garo Armen Honored with WITSA Eminent Person 2024 Award for Cancer Immunotherapy Breakthrough
Vivek Subbiah: Key publications leading to Nobel Prize 2024, published in 1993
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube